| Revenues | 2.5K |
| Research and development costs | 3.59M |
| General and administrative expenses | 1.33M |
| Depreciation and amortization | |
| Total operating expenses | 4.92M |
| Operating loss | -4.92M |
| Litigation settlement | |
| Interest income | 17.29K |
| Interest expense | -240.46K |
| Warrant issuance and modification expense | |
| Gain (loss) from change in fair value adjustment of warrant obligations | |
| Total nonoperating income (expense) | -303.28K |
| Net loss attributable to common shareholders | -5.22M |
| Net loss per share - basic and diluted | -0.05 |
| Weighted average common shares outstanding - basic and diluted | |